From 9 to 12 Hallmarks: What the Aging Framework Explains—and What It Does Not

A shared map, not a complete theory

Aging biology did not begin with the Hallmarks. Researchers already worked with evolutionary theories, damage models, metabolism, cellular senescence, mitochondrial biology, and stem-cell decline. What the 2013 Hallmarks review supplied was synthesis: nine tentative processes arranged in a compact vocabulary that researchers across specialties could use to compare work.

That organizational achievement matters. A shared map can help laboratories frame hypotheses, funders compare programs, and readers connect findings across a fragmented field. Yet influence does not prove that the categories are complete, independent, or ordered correctly. The safest reading is neither dismissal nor reification: critical analyses question the framework’s causal structure while recognizing its value as shared language, not a final theory, individual score, or intervention checklist.

What the original nine were intended to organize

The 2013 review called its nine Hallmarks tentative and grouped them in three categories. Primary Hallmarks were framed as sources of cellular damage: genomic instability, telomere attrition, epigenetic alterations, and loss of proteostasis. Antagonistic Hallmarks were responses that can be protective in some settings but harmful when chronic or excessive: deregulated nutrient sensing, mitochondrial dysfunction, and cellular senescence. Integrative Hallmarks were downstream features associated with organism-level decline: stem cell exhaustion and altered intercellular communication.

Those groups are an organizing proposal, not sealed biological compartments or a proven linear cascade. The original paper explicitly identified the Hallmarks’ interconnectedness and relative contributions as unresolved. Later cause-and-consequence analysis likewise argues that an observed feature may be an initiating influence, a downstream response, a compensation, or several of these at different times.

What changed in the twelve-Hallmark framework

The 2023 update retained all nine original Hallmarks and added three. Disabled macroautophagy formalized impaired cellular recycling and quality control as a separate Hallmark rather than leaving it mainly within proteostasis. Chronic inflammation separated sustained inflammatory signaling from the broader altered-intercellular-communication category. Dysbiosis recognized age-associated changes in host-associated microbial ecosystems and their interaction with organismal physiology.

The additions reflect accumulated evidence and a broader way of organizing it; the underlying processes were not first discovered in 2023. The authors also proposed three premises for Hallmark status: the process should manifest with age, experimental accentuation should accelerate aspects of aging, and experimental intervention should decelerate, stop, or reverse aspects of aging. These are framework criteria, not regulator-approved tests, and the evidence varies by Hallmark, model, tissue, assay, time scale, and outcome.

2013 and 2023: an organizational comparison

The 2023 framework kept the original primary, antagonistic, and integrative organization while redrawing some boundaries. Disabled macroautophagy joined the primary group, but its formal separation does not make autophagy independent of proteostasis or metabolism. The antagonistic group retained deregulated nutrient sensing, mitochondrial dysfunction, and cellular senescence. Chronic inflammation and dysbiosis joined the integrative group, yet both interact with processes across the framework rather than acting as isolated endpoints.

This is a historical and organizational comparison, not a causal ranking. A longer list can make biology more visible without establishing independence, equal validation, clinical actionability, or a permanent count. Comparative evidence remains concentrated in humans and a small set of model organisms, with gaps across species and methods. Tissue, timing, assay, age, and disease context can change what a Hallmark-associated measurement means.

A network, not a checklist

The Hallmarks overlap. Genomic damage can alter transcription and inflammatory signaling. Mitochondrial changes can affect metabolism, stress responses, and senescence. Senescent cells can reshape intercellular communication. Autophagy and proteostasis intersect, while dysbiosis can influence inflammation and metabolism. A change assigned to one category may propagate through several others.

This network character creates two recurring interpretation problems. First, correlation does not reveal whether a measured change is cause, consequence, compensation, or a mixture. Second, naming a process as one Hallmark can hide the cross-level biology that makes it important. The framework remains useful for navigation, but its boxes should not be mistaken for natural, non-overlapping units. Epistemic analysis describes the framework as productive coordination infrastructure while warning that dominant maps can constrain alternatives.

From mechanism to intervention

Experimental work can show that altering a process changes lifespan, pathology, resilience, or molecular readouts in cells or model organisms. That result is valuable evidence about a model under defined conditions. It is not automatically evidence that a human intervention safely changes an aging rate or improves a clinically meaningful outcome. Reviews of Hallmark-targeting claims identify problems involving lifespan proxies, model relevance, comparator choice, exposure, and estimation of intervention effects.

Translation requires defined populations, exposures, safety data, prespecified endpoints, suitable comparators, and enough follow-up. A proof-of-concept trial can reduce uncertainty, but it remains intermediate evidence rather than definitive efficacy. Animal lifespan findings do not automatically establish human benefit, and the framework cannot rank a product by how many Hallmarks it is said to affect.

Hallmarks, biomarkers, and trial endpoints are different layers

A Hallmark is a conceptual or mechanistic category. A biomarker is a measured characteristic interpreted in a defined context. A trial endpoint is an outcome used to assess an intervention. A clinical outcome concerns how a person feels, functions, or survives. These layers may relate, but they are not interchangeable.

The FDA’s qualification overview distinguishes a biomarker from how someone feels, functions, or survives, while qualification applies within a stated context of use. The Hallmarks are not, as a set, qualified surrogate endpoints.

A human-cell study can examine selected relationships between an epigenetic clock and cellular features without showing that clocks measure every Hallmark, diagnose biological age, or predict an individual outcome. A biomarker change may be informative; it is not clinical benefit by definition.

Adjacent frameworks keep the map open

The Hallmarks are not the only organizing vocabulary. The Seven Pillars of geroscience connect aging biology with chronic disease, while Hallmarks of Health proposes a complementary homeostasis-oriented map. Its publisher correction replaced earlier figure drafts but did not alter the limited adjacent-framework use here.

Other perspectives emphasize causes versus consequences, comparative biology, or self-reinforcing frameworks. A later author perspective proposed fourteen Hallmarks by adding extracellular-matrix changes and psychosocial isolation; it framed precision geromedicine as anticipatory and pending trials and regulatory approval, not settled practice.

The durable conclusion is modest. The Hallmarks remain an influential, revisable map for asking better questions. They are most useful when evidence type, model, measurement, causal uncertainty, and translation stage stay visible—and least reliable when converted into a diagnosis, treatment recommendation, biomarker verdict, or promise of human longevity benefit.